These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2000221)

  • 21. Medicinal mushroom extracts inhibit ras-induced cell transformation and the inhibitory effect requires the presence of normal cells.
    Hsiao WL; Li YQ; Lee TL; Li N; You MM; Chang ST
    Carcinogenesis; 2004 Jul; 25(7):1177-83. PubMed ID: 15205366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
    Nielsen C; Thastrup J; Bøttzauw T; Jäättelä M; Kallunki T
    Cancer Res; 2007 Jan; 67(1):178-85. PubMed ID: 17210697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochemical and molecular properties of simian virus 40 transformed Kaposi's sarcoma-derived cells: evidence for the secretion of a member of the fibroblast growth factor family.
    Werner S; Hofschneider PH; Stürzl M; Dick I; Roth WK
    J Cell Physiol; 1989 Dec; 141(3):490-502. PubMed ID: 2556409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
    Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
    Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation can convey resistance to transformation by activated ras oncogene.
    Tzen CY; Maercklein PB; Scott RE
    Anticancer Res; 1990; 10(5A):1329-34. PubMed ID: 2241110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells.
    Reihsaus E; Kohler M; Kraiss S; Oren M; Montenarh M
    Oncogene; 1990 Jan; 5(1):137-45. PubMed ID: 2157179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heat- or stress-inducible transformation-associated cell surface antigen on the activated H-ras oncogene-transfected rat fibroblast.
    Konno A; Sato N; Yagihashi A; Torigoe T; Cho JM; Torimoto K; Hara I; Wada Y; Okubo M; Takahashi N
    Cancer Res; 1989 Dec; 49(23):6578-82. PubMed ID: 2555046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of specific fatty acids on cell transformation induced by an activated c-H-ras oncogene.
    Hsiao WL; Pai HL; Matsui MS; Weinstein IB
    Oncogene; 1990 Mar; 5(3):417-21. PubMed ID: 2107493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cell biology of ras-induced transformation: insights from studies utilizing an inducible hybrid oncogene system.
    Haliotis T; Trimble W; Chow S; Mills G; Girard P; Kuo JF; Govindji N; Hozumi N
    Anticancer Res; 1988; 8(5A):935-45. PubMed ID: 2845854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of levels and kinetics of H-ras expression to transformed phenotype and loss of TGF-beta 1-mediated growth regulation in intestinal epithelial cells.
    Zhao J; Buick RN
    Exp Cell Res; 1993 Jan; 204(1):82-7. PubMed ID: 8416798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Constitutive activity of MAP kinase cascades in REF cells transformed by E1A and cHa-ras oncogenes].
    Svetlikova SB; Abramova MV; Kukushkin AN; Darieva ZA; Pospelova TV; Pospelov VA
    Tsitologiia; 2001; 43(10):961-8. PubMed ID: 11769129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p21ras independent down-regulation of ras-induced increases in natural antibody binding during tumor progression.
    Tough DF; Feng X; Chow DA
    Nat Immun; 1995; 14(1):20-34. PubMed ID: 7599459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
    Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
    Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene.
    Hirakawa T; Ruley HE
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1519-23. PubMed ID: 2830621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Massive accumulation of neutral lipids in cells conditionally transformed by an activated H-ras oncogene.
    Hirakawa T; Maruyama K; Kohl NE; Kodama T; Ruley HE
    Oncogene; 1991 Feb; 6(2):289-95. PubMed ID: 2000221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.